Pages that link to "Q26740187"

The following pages link to Novel drugs that target the metabolic reprogramming in renal cell cancer (Q26740187):

Displaying 21 items.

• The proteomic landscape of renal tumors. (Q38803559) (← links)
• Metabolic reprogramming in clear cell renal cell carcinoma (Q39290307) (← links)
• Understanding tumor anabolism and patient catabolism in cancer-associated cachexia (Q39339489) (← links)
• Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets (Q39340415) (← links)
• Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells. (Q47754576) (← links)
• The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation (Q49678727) (← links)
• Metabolomics and Metabolic Reprogramming in Kidney Cancer. (Q52618376) (← links)
• Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy. (Q52661722) (← links)
• Renal cell carcinoma: a review of biology and pathophysiology. (Q52724797) (← links)
• Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma. (Q52899766) (← links)
• Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma. (Q52902527) (← links)
• Non-Invasive Assessment of Lactate Production and Compartmentalization in Renal Cell Carcinomas Using Hyperpolarized C Pyruvate MRI (Q57160517) (← links)
• Prolyl isomerase Pin1: a promoter of cancer and a target for therapy (Q58695611) (← links)
• Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing (Q64076854) (← links)
• The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy (Q64237577) (← links)
• The Design and Synthesis of N-Xanthone Benzenesulfonamides as Novel Phosphoglycerate Mutase 1 (PGAM1) Inhibitors (Q89065818) (← links)
• The Flick of a Switch: Conferring Survival Advantage to Breast Cancer Stem Cells Through Metabolic Plasticity (Q90266815) (← links)
• Oncometabolites in renal cancer (Q90860049) (← links)
• The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma (Q93102798) (← links)
• Caveolin-1 inhibits breast cancer stem cells via c-Myc-mediated metabolic reprogramming (Q96302711) (← links)
• Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells (Q107270365) (← links)